Henry J. Fuchs, EVP, Chief Medical Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 15,000 shares at $95.06 ($1.4M) on 2016-08-26, disclosed to the SEC on 2016-08-30.
Open-market sale of $1.4M BMRN by EVP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MRTX | SELL | 2022-02-14 | $1.4M | — | Filing → |
| MRTX | SELL | 2020-12-16 | $4.7M | — | Filing → |
| MRTX | SELL | 2020-08-11 | $1.6M | — | Filing → |